BIOSPECIFICS TECHNOLOGIES CO's ticker is BSTC and the CUSIP is 090931106. A total of 114 filers reported holding BIOSPECIFICS TECHNOLOGIES CO in Q3 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2020 | $298,000 | -2.0% | 4,869 | -9.3% | 0.00% | – |
| Q1 2020 | $304,000 | -21.0% | 5,369 | -20.7% | 0.00% | – |
| Q4 2019 | $385,000 | +6.4% | 6,769 | 0.0% | 0.00% | – |
| Q3 2019 | $362,000 | -10.4% | 6,769 | 0.0% | 0.00% | -100.0% |
| Q2 2019 | $404,000 | +87.9% | 6,769 | +96.2% | 0.00% | – |
| Q1 2019 | $215,000 | -54.5% | 3,450 | -55.8% | 0.00% | -100.0% |
| Q4 2018 | $473,000 | -32.9% | 7,804 | -35.3% | 0.00% | 0.0% |
| Q3 2018 | $705,000 | +24.8% | 12,061 | -4.3% | 0.00% | 0.0% |
| Q2 2018 | $565,000 | +22.0% | 12,601 | +20.7% | 0.00% | 0.0% |
| Q1 2018 | $463,000 | +12.1% | 10,436 | +9.4% | 0.00% | 0.0% |
| Q4 2017 | $413,000 | +60.7% | 9,536 | +72.4% | 0.00% | – |
| Q3 2017 | $257,000 | – | 5,531 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JW Asset Management, LLC | 73,649 | $3,646,000 | 2.32% |
| Stonepine Capital Management, LLC | 59,878 | $2,965,000 | 1.60% |
| NORTHPOINTE CAPITAL LLC | 109,644 | $5,428,000 | 0.57% |
| Elk Creek Partners, LLC | 145,406 | $7,199,000 | 0.47% |
| TFS CAPITAL LLC | 18,208 | $901,000 | 0.35% |
| RICE HALL JAMES & ASSOCIATES, LLC | 161,671 | $8,004,000 | 0.35% |
| Ativo Capital Management LLC | 19,592 | $970,000 | 0.26% |
| Matarin Capital Management, LLC | 57,034 | $2,823,753,000 | 0.26% |
| ISTHMUS PARTNERS, LLC | 16,505 | $817,000 | 0.24% |
| Stanley-Laman Group, Ltd. | 12,546 | $621,000 | 0.17% |